Next Article in Journal
Biosimilars: Company Strategies to Capture Value from the Biologics Market
Next Article in Special Issue
Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy
Previous Article in Journal
Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent
Previous Article in Special Issue
Physical Factors Affecting Plasmid DNA Compaction in Stearylamine-Containing Nanoemulsions Intended for Gene Delivery
Pharmaceuticals 2012, 5(12), 1372-1392; doi:10.3390/ph5121372

Notes on Article Versions

article html file updated24 January 2013 10:44 CET
article html file updated7 February 2013 17:19 CET
article xml file uploaded13 September 2013 17:15 CEST
article html file updated13 September 2013 17:15 CEST
article html file updated17 June 2015 04:41 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert